Keywords: novartis, tyzeka, cleared, usa, hbv, swiss, drug

Novartis' Tyzeka cleared in the USA for HBV

Article | 30 October 2006

Print This

Swiss drug major Novartis says that Tyzeka (telbivudine) has been approved in the USA as a new once-a-day oral treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in